“…Interestingly, the constructed CIDM displayed OXD-mimic activity, which could facilitate the modulation of m 6 A methylation. [50][51][52] As a proof of concept, we applied this strategy to reprogram macrophage polarization into the bactericidal M1 phenotype for efficient bacterial ablation. 15,16,53,54 Such a bioorthogonal chemistrycontrolled epigenetics regulatory strategy could achieve a maximized treatment outcome and a minimized drug side effect, which provided an important insight into the development of in situ controllable m 6 A methylation.…”